Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
BACKGROUND:Few data have described long-term outcomes for infants born to HIV-infected African women taking antiretroviral therapy (ART) in pregnancy. This is particularly true for World Health Organization (WHO)-recommended tenofovir-containing first-line regimens, which are increasingly used and k...
Main Authors: | Diana M Gibb, Hilda Kizito, Elizabeth C Russell, Ennie Chidziva, Eva Zalwango, Ruth Nalumenya, Moira Spyer, Dinah Tumukunde, Kusum Nathoo, Paula Munderi, Hope Kyomugisha, James Hakim, Heiner Grosskurth, Charles F Gilks, A Sarah Walker, Phillipa Musoke, DART trial team |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC3352861?pdf=render |
Similar Items
-
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
by: Gibb, D, et al.
Published: (2012) -
DART and laboratory monitoring of HIV treatment Reply
by: Walker, A, et al.
Published: (2010) -
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
by: Mugyenyi, P, et al.
Published: (2010) -
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
by: Ssali, F, et al.
Published: (2006) -
Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
by: Walker, A, et al.
Published: (2010)